Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 15.44 USD 3.14% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Progyny Inc?
Write Note

Progyny Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Progyny Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Progyny Inc
NASDAQ:PGNY
Revenue
$1.1B
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
N/A
UnitedHealth Group Inc
NYSE:UNH
Revenue
$393.9B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
12%
Centene Corp
NYSE:CNC
Revenue
$161.7B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
27%
Molina Healthcare Inc
NYSE:MOH
Revenue
$39.2B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
16%
Humana Inc
NYSE:HUM
Revenue
$115B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
10%
Elevance Health Inc
NYSE:ELV
Revenue
$174B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
9%
No Stocks Found

Progyny Inc
Revenue Breakdown

Breakdown by Geography
Progyny Inc

Not Available

Breakdown by Segments
Progyny Inc

Total Revenue: 1.1B USD
100%
Fertility Benefit Services Revenue: 676.3m USD
62.1%
Pharmacy Benefit Services Revenue: 412.3m USD
37.9%

Progyny Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

PGNY Intrinsic Value
38.38 USD
Undervaluation 60%
Intrinsic Value
Price

See Also

What is Progyny Inc's Revenue?
Revenue
1.1B USD

Based on the financial report for Sep 30, 2024, Progyny Inc's Revenue amounts to 1.1B USD.

What is Progyny Inc's Revenue growth rate?
Revenue CAGR 5Y
42%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Progyny Inc have been 34% over the past three years , 42% over the past five years .

Back to Top